TRUEMETRIX
Report
- Report Number
- 1000113657-2017-01638
- Event Type
- Malfunction
- Date Received
- August 30, 2017
- Date of Event
- August 17, 2017
- Report Date
- August 30, 2017
- Manufacturer
- TRIVIDIA HEALTH, INC.
- Product Code
- NBW
- UDI-DI
- 00021292007041
- PMA / PMN Number
- K140100
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SC
- Reporter Occupation
- OTHER
Narratives
(B)(4). RETURNED METER EVALUATED WITH NO DEFECT FOUND. TEST STRIPS NOT RETURNED FOR EVALUATION. MOST LIKELY UNDERLYING ROOT CAUSE: MLC-20-USER'S TEST STRIP HAD POOR STORAGE (KITCHEN). (B)(4).
CONSUMER REPORTED COMPLAINT FOR HIGH BLOOD GLUCOSE TEST RESULTS. THE CUSTOMER IS CONCERNED WITH TEST RESULTS FROM RESULTS OBTAINED OF 332, 297 AND 198 MG/DL. THE CUSTOMER IS ALSO CONCERNED THAT THE RESULTS OBTAINED OF 332 AND 297 MG/DL ARE ERRATIC. THE CUSTOMER'S EXPECTED FASTING BLOOD GLUCOSE TEST RESULT RANGE IS 100 - 155 MG/DL. THE CUSTOMER FEELS WELL AND DID NOT REPORT ANY SYMPTOMS. MEDICAL ATTENTION IS NOT REPORTED AS A RESULT OF THE ACTUAL BLOOD GLUCOSE RESULTS. DURING THE CALL ON (B)(6) 2017, A BACK TO BACK BLOOD TEST WAS NOT PERFORMED BY THE CUSTOMER. THE PRODUCT IS NOT STORED ACCORDING TO SPECIFICATION AND IS STORED IN THE KITCHEN. THE TEST STRIP LOT MANUFACTURER'S EXPIRATION DATE IS 09/28/2018 AND OPEN VIAL DATE IS (B)(6) 2017. THE METER MEMORY WAS REVIEWED FOR PREVIOUS TEST RESULT HISTORY: 198MG/DL (B)(6) 2017 07:24 AM FASTING:YES, 297MG/DL (B)(6) 2017 09:22 PM FASTING:YES, 332MG/DL (B)(6) 2017 09:21 PM FASTING:YES, 166MG/DL (B)(6) 2017 08:04 AM FASTING:YES, 166MG/DL (B)(6) 2017 10:06 PM FASTING:YES. MEMORY CONCERNS:CUSTOMER IS CONCERNED WITH 332, 297 AND 198MG/DL FASTING RESULTS. CUSTOMER IS ALSO CONCERNED ABOUT 332 AND 297MG/DL ERRATIC FASTING RESULTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 610618 | TRUEMETRIX | BLOOD GLUCOSE SYSTEM | NBW | TRIVIDIA HEALTH, INC. | TRUEMETRIX | MU2414 | 00021292007041 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 0 YR | SECOND THERAPY |